IRUS Total

Past, present, and future of global health financing: A review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995–2050

File Description SizeFormat 
Rawaf.Past.Present & Future.main.pdfPublished version5.94 MBAdobe PDFView/Open
Title: Past, present, and future of global health financing: A review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995–2050
Authors: Chang, AY
Cowling, K
Micah, AE
Chapin, A
Chen, CS
Ikilezi, G
Sadat, N
Tsakalos, G
Wu, J
Younker, T
Zhao, Y
Zlavog, BS
Abbafati, C
Ahmed, AE
Alam, K
Alipour, V
Aljunid, SM
Almalki, MJ
Alvis-Guzman, N
Ammar, W
Andrei, CL
Anjomshoa, M
Antonio, CAT
Arabloo, J
Aremu, O
Ausloos, M
Avila-Burgos, L
Awasthi, A
Ayanore, MA
Azari, S
Azzopardi-Muscat, N
Bagherzadeh, M
Bärnighausen, TW
Baune, BT
Bayati, M
Belay, YB
Belay, YA
Belete, H
Berbada, DA
Berman, AE
Beuran, M
Bijani, A
Busse, R
Cahuana-Hurtado, L
Cámera, LA
Catalá-López, F
Chauhan, BG
Constantin, M-M
Crowe, CS
Cucu, A
Dalal, K
De Neve, J-W
Deiparine, S
Demeke, FM
Do, HP
Dubey, M
El Tantawi, M
Eskandarieh, S
Esmaeili, R
Fakhar, M
Fazaeli, AA
Fischer, F
Foigt, NA
Fukumoto, T
Fullman, N
Galan, A
Gamkrelidze, A
Gezae, KE
Ghajar, A
Ghashghaee, A
Goginashvili, K
Haakenstad, A
Haghparast Bidgoli, H
Hamidi, S
Harb, HL
Hasanpoor, E
Hassen, HY
Hay, SI
Hendrie, D
Henok, A
Heredia-Pi, I
Herteliu, C
Hoang, CL
Hole, MK
Homaie Rad, E
Hossain, N
Hosseinzadeh, M
Hostiuc, S
Ilesanmi, OS
Irvani, SSN
Jakovljevic, M
Jalali, A
James, SL
Jonas, JB
Jürisson, M
Kadel, R
Karami Matin, B
Kasaeian, A
Kasaye, HK
Kassaw, MW
Kazemi Karyani, A
Khabiri, R
Khan, J
Khan, MN
Khang, Y-H
Kisa, A
Kissimova-Skarbek, K
Kohler, S
Koyanagi, A
Krohn, KJ
Leung, R
Lim, L-L
Lorkowski, S
Majeed, A
Malekzadeh, R
Mansourian, M
Mantovani, LG
Massenburg, BB
McKee, M
Mehta, V
Meretoja, A
Meretoja, TJ
Milevska Kostova, N
Miller, TR
Mirrakhimov, EM
Mohajer, B
Mohammad Darwesh, A
Mohammed, S
Mohebi, F
Mokdad, AH
Morrison, SD
Mousavi, SM
Muthupandian, S
Nagarajan, AJ
Nangia, V
Negoi, I
Nguyen, CT
Nguyen, HLT
Nguyen, SH
Nosratnejad, S
Oladimeji, O
Olgiati, S
Olusanya, JO
Onwujekwe, OE
Otstavnov, SS
Pana, A
Pereira, DM
Piroozi, B
Prada, SI
Qorbani, M
Rabiee, M
Rabiee, N
Rafiei, A
Rahim, F
Rahimi-Movaghar, V
Ram, U
Ranabhat, CL
Ranta, A
Rawaf, DL
Rawaf, S
Rezaei, S
Roro, EM
Rostami, A
Rubino, S
Salahshoor, M
Samy, AM
Sanabria, J
Santos, JV
Santric Milicevic, MM
Sao Jose, BP
Savic, M
Schwendicke, F
Sepanlou, SG
Sepehrimanesh, M
Sheikh, A
Shrime, MG
Sisay, S
Soltani, S
Soofi, M
Soofi, M
Srinivasan, V
Tabarés-Seisdedos, R
Torre, A
Tovani-Palone, MR
Tran, BX
Tran, KB
Undurraga, EA
Valdez, PR
Van Boven, JFM
Vargas, V
Veisani, Y
Violante, FS
Vladimirov, SK
Vlassov, V
Vollmer, S
Vu, GT
Wolfe, CDA
Yonemoto, N
Younis, MZ
Yousefifard, M
Zaman, SB
Zangeneh, A
Zegeye, EA
Ziapour, A
Chew, A
Murray, CJL
Dieleman, JL
Item Type: Journal Article
Abstract: Summary Background Comprehensive and comparable estimates of health spending in each country are a key input for health policy and planning, and are necessary to support the achievement of national and international health goals. Previous studies have tracked past and projected future health spending until 2040 and shown that, with economic development, countries tend to spend more on health per capita, with a decreasing share of spending from development assistance and out-of-pocket sources. We aimed to characterise the past, present, and predicted future of global health spending, with an emphasis on equity in spending across countries. Methods We estimated domestic health spending for 195 countries and territories from 1995 to 2016, split into three categories—government, out-of-pocket, and prepaid private health spending—and estimated development assistance for health (DAH) from 1990 to 2018. We estimated future scenarios of health spending using an ensemble of linear mixed-effects models with time series specifications to project domestic health spending from 2017 through 2050 and DAH from 2019 through 2050. Data were extracted from a broad set of sources tracking health spending and revenue, and were standardised and converted to inflation-adjusted 2018 US dollars. Incomplete or low-quality data were modelled and uncertainty was estimated, leading to a complete data series of total, government, prepaid private, and out-of-pocket health spending, and DAH. Estimates are reported in 2018 US dollars, 2018 purchasing-power parity-adjusted dollars, and as a percentage of gross domestic product. We used demographic decomposition methods to assess a set of factors associated with changes in government health spending between 1995 and 2016 and to examine evidence to support the theory of the health financing transition. We projected two alternative future scenarios based on higher government health spending to assess the potential ability of governments to generate more resources for health. Findings Between 1995 and 2016, health spending grew at a rate of 4·00% (95% uncertainty interval 3·89–4·12) annually, although it grew slower in per capita terms (2·72% [2·61–2·84]) and increased by less than $1 per capita over this period in 22 of 195 countries. The highest annual growth rates in per capita health spending were observed in upper-middle-income countries (5·55% [5·18–5·95]), mainly due to growth in government health spending, and in lower-middle-income countries (3·71% [3·10–4·34]), mainly from DAH. Health spending globally reached $8·0 trillion (7·8–8·1) in 2016 (comprising 8·6% [8·4–8·7] of the global economy and $10·3 trillion [10·1–10·6] in purchasing-power parity-adjusted dollars), with a per capita spending of US$5252 (5184–5319) in high-income countries, $491 (461–524) in upper-middle-income countries, $81 (74–89) in lower-middle-income countries, and $40 (38–43) in low-income countries. In 2016, 0·4% (0·3–0·4) of health spending globally was in low-income countries, despite these countries comprising 10·0% of the global population. In 2018, the largest proportion of DAH targeted HIV/AIDS ($9·5 billion, 24·3% of total DAH), although spending on other infectious diseases (excluding tuberculosis and malaria) grew fastest from 2010 to 2018 (6·27% per year). The leading sources of DAH were the USA and private philanthropy (excluding corporate donations and the Bill & Melinda Gates Foundation). For the first time, we included estimates of China's contribution to DAH ($644·7 million in 2018). Globally, health spending is projected to increase to $15·0 trillion (14·0–16·0) by 2050 (reaching 9·4% [7·6–11·3] of the global economy and $21·3 trillion [19·8–23·1] in purchasing-power parity-adjusted dollars), but at a lower growth rate of 1·84% (1·68–2·02) annually, and with continuing disparities in spending between countries. In 2050, we estimate that 0·6% (0·6–0·7) of health spending will occur in currently low-income countries, despite these countries comprising an estimated 15·7% of the global population by 2050. The ratio between per capita health spending in high-income and low-income countries was 130·2 (122·9–136·9) in 2016 and is projected to remain at similar levels in 2050 (125·9 [113·7–138·1]). The decomposition analysis identified governments’ increased prioritisation of the health sector and economic development as the strongest factors associated with increases in government health spending globally. Future government health spending scenarios suggest that, with greater prioritisation of the health sector and increased government spending, health spending per capita could more than double, with greater impacts in countries that currently have the lowest levels of government health spending. Interpretation Financing for global health has increased steadily over the past two decades and is projected to continue increasing in the future, although at a slower pace of growth and with persistent disparities in per-capita health spending between countries. Out-of-pocket spending is projected to remain substantial outside of high-income countries. Many low-income countries are expected to remain dependent on development assistance, although with greater government spending, larger investments in health are feasible. In the absence of sustained new investments in health, increasing efficiency in health spending is essential to meet global health targets. Funding Bill & Melinda Gates Foundation.
Issue Date: 1-Jun-2020
Date of Acceptance: 7-Mar-2019
URI: http://hdl.handle.net/10044/1/69867
DOI: 10.1016/s0140-6736(19)30841-4
ISSN: 0140-6736
Publisher: Elsevier
Start Page: 2233
End Page: 2260
Journal / Book Title: The Lancet
Volume: 393
Issue: 10187
Copyright Statement: © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license https://creativecommons.org/licenses/by/4.0/legalcode.
Keywords: Science & Technology
Life Sciences & Biomedicine
Medicine, General & Internal
General & Internal Medicine
Global Health
Gross Domestic Product
Health Expenditures
Healthcare Financing
Models, Economic
Prepaid Health Plans
Public Assistance
Global Burden of Disease Health Financing Collaborator Network
Models, Economic
Health Expenditures
Public Assistance
Prepaid Health Plans
Gross Domestic Product
Healthcare Financing
Global Health
General & Internal Medicine
11 Medical and Health Sciences
Publication Status: Published
Online Publication Date: 2019-04-25
Appears in Collections:School of Public Health

Unless otherwise indicated, items in Spiral are protected by copyright and are licensed under a Creative Commons Attribution NonCommercial NoDerivatives License.

Creative Commons